ARTICLE | Distillery Therapeutics
Neurology
February 28, 2018 6:13 PM UTC
Cell culture and rat studies identified a KCNIP3-based inhibitor of TRPV1 that could help treat inflammatory pain. In a cell-based activity assay, an N-terminal fragment of KCNIP3 (residues 31-50) dec...